Company profile TLIS

Talis Biomedical Corp
high complexity diagnostics at the point-of-need. bridging the gap between discovery and delivery at slipchip we integrate high-complexity laboratory assays, into an easy to perform, affordable and accessible sample-to-answer format across a wide range of environments. what if physicians could make rapid, individualized optimal treatment decisions? today, patients are often for...ced to endure days of waiting for lab results. as a result, doctors initially treat everyone with a strong cocktail of drugs. this approach is costly and can be harmful to patients.it also leads to serious drug resistance problems. our technology will allow doctors to provide optimal therapies to patients sooner. empowering physicians to make informed treatment decisions quickly. minimizing risks and reducing patient recovery times. Show More
Quarter analysis & expected interest

There is not enough data for Talis Biomedical -revenue to provide analysis

Correlation between past revenue and Talis Biomedical -revenue search interest

There is not enough data for Talis Biomedical -revenue to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Talis Biomedical -revenue to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Talis Biomedical -stock to provide analysis

Correlation between past revenue and Talis Biomedical -stock search interest

There is not enough data for Talis Biomedical -stock to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Talis Biomedical -stock to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Talis One system to provide analysis

Correlation between past revenue and Talis One system search interest

There is not enough data for Talis One system to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Talis One system to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Talis One tests to provide analysis

Correlation between past revenue and Talis One tests search interest

There is not enough data for Talis One tests to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Talis One tests to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:32:40.

After 39 days of this quarter the interest is at 165.0. Based on that we can calculate that during remaining 52 days it will total up to 385.0.
infectious diseases testing expected interest is significantly higher compared to previous quarter (+352.9%) and same quarter last year (+332.6%).

YearQ1Q2Q3Q4
201968
69
1.5% QoQ
57
-17.4% QoQ
50
-12.3% QoQ
2020 104
52.9% YoY 108.0% QoQ
108
56.5% YoY 3.8% QoQ
75
31.6% YoY -30.6% QoQ
89
78.0% YoY 18.7% QoQ
2021 63
-39.4% YoY -29.2% QoQ
0
-100.0% YoY -100.0% QoQ
32
-57.3% YoY inf% QoQ
77
-13.5% YoY 140.6% QoQ
2022 167
165.1% YoY 116.9% QoQ
63
inf% YoY -62.3% QoQ
35
9.4% YoY -44.4% QoQ
76
-1.3% YoY 117.1% QoQ
2023 89
-46.7% YoY 17.1% QoQ
70
11.1% YoY -21.3% QoQ
85
142.9% YoY 21.4% QoQ
85
11.8% YoY 0.0% QoQ
2024 165
85.4% YoY 94.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and infectious diseases testing search interestLast update: February 09 2024 18:32:38.
Correlation coefficient between keyword and revenue is -0.9
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:32:41.

The average 5 years interest of infectious diseases testing was 6.23 per week.
The last year interest of infectious diseases testing compared to the last 5 years has changed by 42.05%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 88.7%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for respiratory infections testing to provide analysis

Correlation between past revenue and respiratory infections testing search interest

There is not enough data for respiratory infections testing to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for respiratory infections testing to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for women's health infections testing to provide analysis

Correlation between past revenue and women's health infections testing search interest

There is not enough data for women's health infections testing to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for women's health infections testing to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for sexually transmitted infections testing to provide analysis

Correlation between past revenue and sexually transmitted infections testing search interest

There is not enough data for sexually transmitted infections testing to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for sexually transmitted infections testing to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:32:45.

After 39 days of this quarter the interest is at 37.0. Based on that we can calculate that during remaining 52 days it will total up to 86.0.
respiratory panel test expected interest is significantly lower compared to previous quarter (-58.9%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201910
22
120.0% QoQ
53
140.9% QoQ
39
-26.4% QoQ
2020 316
3060.0% YoY 710.3% QoQ
56
154.5% YoY -82.3% QoQ
45
-15.1% YoY -19.6% QoQ
113
189.7% YoY 151.1% QoQ
2021 72
-77.2% YoY -36.3% QoQ
94
67.9% YoY 30.6% QoQ
203
351.1% YoY 116.0% QoQ
311
175.2% YoY 53.2% QoQ
2022 212
194.4% YoY -31.8% QoQ
146
55.3% YoY -31.1% QoQ
62
-69.5% YoY -57.5% QoQ
177
-43.1% YoY 185.5% QoQ
2023 141
-33.5% YoY -20.3% QoQ
113
-22.6% YoY -19.9% QoQ
142
129.0% YoY 25.7% QoQ
209
18.1% YoY 47.2% QoQ
2024 37
-73.8% YoY -82.3% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and respiratory panel test search interestLast update: February 09 2024 18:32:45.
Correlation coefficient between keyword and revenue is -0.8
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:32:46.

The average 5 years interest of respiratory panel test was 9.86 per week.
The last year interest of respiratory panel test compared to the last 5 years has changed by 11.56%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 244.83%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for TLIS
Earnings date: 2024-03-20 After close
Company name: Talis Biomedical Corp
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2024-10-10T17:01:39-04:00

SEC
SC 13D/A Form - [Amend] General Statement of Acquisition of Beneficial Ownership - Talis Biomedical Corp (0001584751) (Subject)

2024-09-30T06:05:56-04:00

SEC
15-12G Form - Securities registration termination [Section 12(g)] - Talis Biomedical Corp (0001584751) (Filer)

2024-09-20T08:57:32-04:00

SEC
25-NSE Form - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities - Talis Biomedical Corp (0001584751) (Subject)

2024-09-17T16:11:46-04:00

SEC
8-K Form - Current report, items 1.01 and 9.01 - Talis Biomedical Corp (0001584751) (Filer)

2024-09-09T16:37:20-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Talis Biomedical Corp (0001584751) (Filer)

2024-09-09T16:37:19-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Talis Biomedical Corp (0001584751) (Filer)

2024-09-09T16:33:24-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Talis Biomedical Corp (0001584751) (Filer)

2024-09-09T16:32:00-04:00

SEC
S-8 POS Form - Securities to be offered to employees in employee benefit plans, post-effective amendments - Talis Biomedical Corp (0001584751) (Filer)

2024-09-09T16:24:12-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Talis Biomedical Corp (0001584751) (Issuer)

2024-09-06T16:12:09-04:00

SEC
8-K Form - Current report, items 1.01 and 9.01 - Talis Biomedical Corp (0001584751) (Filer)

2024-09-05T17:11:01-04:00

SEC
8-K/A Form - [Amend] Current report, items 1.01 and 9.01 - Talis Biomedical Corp (0001584751) (Filer)

2024-09-05T11:57:28-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Talis Biomedical Corp (0001584751) (Issuer)

2024-09-04T20:19:50-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Talis Biomedical Corp (0001584751) (Issuer)

2024-09-03T17:13:15-04:00

SEC
8-K Form - Current report, items 1.01 and 9.01 - Talis Biomedical Corp (0001584751) (Filer)

2024-08-28T16:45:05-04:00

SEC
4 Form - Statement of changes in beneficial ownership of securities - Talis Biomedical Corp (0001584751) (Issuer)